Chooses subgroup specific optimal doses in a phase I dose finding clinical trial allowing for subgroup combination and simulates clinical trials under the subgroup specific time to event continual reassessment method. Chapple, A.G., Thall, P.F. (2018) <doi:10.1002/pst.1891>.
https://anaconda.org/r/r-subtite/badges/version.svg
https://anaconda.org/r/r-subtite/badges/latest_release_date.svg
https://anaconda.org/r/r-subtite/badges/latest_release_relative_date.svg
https://anaconda.org/r/r-subtite/badges/platforms.svg
https://anaconda.org/r/r-subtite/badges/license.svg
https://anaconda.org/r/r-subtite/badges/downloads.svg